TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Adolescents' overall reply rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction with contraceptive patch
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Compliance with contraceptive method
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvements in premenstrual symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dose of propofol used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: willingness to repeat sedation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Culture-positive sore throats
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Median time in days to remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: middle cerebral artery mean flow velocity (MFV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cerebrovascular outcomes
Primary endpoint: jugular bulb oxygen saturation (jSvO₂)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cerebral lactate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in the severity of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: favorable 3-month outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Depth of sedation (RASS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: smoking cessation outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of large or occlusive deep-vein thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Development of deep-vein thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Units of blood required during hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Poor depression treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related quality of life outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intensive care unit stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Adequacy of thromboprophylaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OHIP-20 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total number of sore spots
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge about the existence of Rare Disease Day
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accurate specification of the aim of Rare Disease Day
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Personal concern about Rare Disease Day
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Number of nonmelanoma skin cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Comfort immediately on insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort during the day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wearing times with SH lenses
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: reduced gastrointestinal noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Peripheral sensory neuropathy (PSN)
Endpoint domain: Adverse events/effects
Primary endpoint: Refractive error treatment coverage rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mother's satisfaction with professional and social support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Professionals' attitudes toward breastfeeding and parental support
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: remodeling response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Death or moderate/severe disability
Endpoint domain: Mortality/survival
Primary endpoint: MADRS mean change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pooled remission rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crypt length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bioavailability of rocuronium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration peak time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy Eating Index at 36 weeks gestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24 h levels of vWF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: nocturnal levels of FVIII
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: nocturnal levels of FV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean ACQ change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain sensitivity after tooth bleaching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical efficiency rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TEQ scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of patients experiencing the primary outcome
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of primary endpoint
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery of dental structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SSV improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcome quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Average fracture displacement at 300 N
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WML volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitude toward smoking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Non-smoking efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of clinical abacavir hypersensitivity reaction (HSR)
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in facial wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deposition of fibrillin-1 in skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: six-month pregnancy rate during typical use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: clinical failure rates (breakage and slippage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Prevention of ischemic stroke and systemic embolism
Endpoint domain: Mortality/survival
Primary endpoint: Uptake of screening colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Pancreatic Fistula (POPF)
Endpoint domain: Adverse events/effects
Primary endpoint: Hematoma volume growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional outcomes at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: percentage of uncovered strut by neointima
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: frequency of stent with evagination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Proportion of tacrolimus concentrations within target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Curve size progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 7-day latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: composite neonatal morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: PCa diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Postoperative temporal hollowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endoscopic polyp grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lund-Mackay CT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in fasting glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: one-year event-free survival
Endpoint domain: Mortality/survival
Primary endpoint: incidence of cardiac deaths
Endpoint domain: Mortality/survival
Primary endpoint: incidence of myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Pharyngolaryngeal morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rates of hypopneic hypoventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rates of bradypnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative chest infections
Endpoint domain: Adverse events/effects
Primary endpoint: Kidney damage markers (urinary NGAL/creatinine ratio, urea, creatinine, eGFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Composite of clinical endpoints (death, strokes, myocardial infarctions)
Endpoint domain: Mortality/survival
Primary endpoint: Delivery rate in the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of slow flow after PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ST segment resolution >50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 5 years' freedom from MACEs
Endpoint domain: Mortality/survival
Primary endpoint: students' understanding
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: students' confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in hand function related to grasping small objects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of ulnar nerve injury
Endpoint domain: Adverse events/effects
Primary endpoint: regression to normoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: discontinuation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete upper gastrointestinal symptom relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: improvement of heartburn symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: sensitivity for detection of amblyopia risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity for detection of amblyopia risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bioavailability of AMPH ER TAB compared to AMPH EROS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak exposure (Cmax) of d- and l-amphetamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to peak concentration (Tmax) of d- and l-amphetamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful temporary weaning from LVAD support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak change in pulmonary capillary wedge pressure (PCWP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients with metavir activity grade improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early antidepressant response detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total duration of diarrhea episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of diarrhea episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Combined craniocervical movement from occiput to C5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: improvements in hearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speech discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tinnitus remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 25‐OH‐vitamin D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: early improvement of depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RARbeta mRNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of diabetes among tuberculosis patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of statins prescribed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of statins dispensed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Surgical time required for implant placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Patient preference for technique
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Measurement of albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nutritional requirement verification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in TPN components
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to complete NTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of Ki‐67, p53 and Bcl‐2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hip fracture
Endpoint domain: Mortality/survival
Primary endpoint: telomere lengthening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age-standardized prevalence of diastolic LV dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mRNA levels of IL-1alpha and IL-1beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: spontaneous release of IL-1beta and IL-1Ra
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean inspiratory compound A exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative agitation incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Peroperative heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LVSF (Left Ventricular Systolic Function)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of PEECS
Endpoint domain: Adverse events/effects
Primary endpoint: VAS scores for abdominal pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Remission rates on the Beck Depression Inventory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission rates on the Hamilton Depression Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of severe rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: freedom from allograft vasculopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: mean breathlessness score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ease of mucus expectoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genetically predicted ETP association with IHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AF and antiarrhythmic drug-free survival
Endpoint domain: Mortality/survival
Primary endpoint: trauma symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: glycemic index (GI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC(0-infinity) of rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: any complications
Endpoint domain: Adverse events/effects
Primary endpoint: Subjective symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tear film break up time (BUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remnant cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Apolipoprotein B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Corneal tissue concentration of levofloxacin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aqueous humor concentration of levofloxacin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of symptoms and disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean weight loss over 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to eat as much as they liked
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Appetite improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fasting antral phase III migrating motor complexes (MMCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Increased antral motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of patients arrhythmia-free after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to symptom return for injection number 1 and 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Stability Index (OSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean C(max) of metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ClCr before and after CM exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Lymph node metastasis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Healing of erosive gastroesophageal reflux disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Resolution or improvement of heartburn symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Inpatient readmissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Readiness and Motivation Questionnaire (RMQ) action scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effect on nursing staff's interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median abdominal NIRS value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median lactate from the inferior vena cava
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Biomarkers for renal and intestinal damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Internal consistency of Brief WISDM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Long-term stability of Brief WISDM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concurrent validity of Brief WISDM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: reduced frequency of problem behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced objective caregiver burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: greater mastery and self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: inflammatory markers and cytokine receptors levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: polymorphonuclear leukocyte‐elastase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: clinical restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes